1.
SSIs are believed to account for $3.5 billion to $10 billion annually in healthcare expenditures using the CPI (consumer price index for inpatient hospital services with all cost estimates adjusted for 2007 dollars). 6 
SECTION 2 : BACKGROUND-STRATEGIES TO DETECT SSI

I. Surveillance definitions
A. The Centers for Disease Control and Prevention's (CDC's) National
Healthcare Safety Network (NHSN) definitions for SSI are widely used for public reporting, interfacility comparison, and pay-for-performance comparisons. 26 B. SSIs are classified ( Figure 1 ) as follows:
1. Superficial incisional (involving only skin or subcutaneous tissue of the incision).
Deep incisional (involving fascia and/or muscular layers).
a. Deep incision primary (DIP)-SSI identified in a primary incision in a patient who has had an operation with 1 or more incisions.
days versus 1 year for an implant-related procedure). A pilot study in general surgery reported that 10.5% of SSIs following colon procedures were identified after discharge from the hospital. 52 
5.
By improving completeness of reporting, the overall institutional SSI rate typically increases after post-discharge surveillance methods are implemented regardless of which method is used. 43, 44, 53 a. To improve interfacility comparisons and minimize potential bias introduced by differences in post-discharge surveillance methods, national public reporting focuses on nonsuperficial incisional SSIs detected during hospitalization for the index procedure or after discharge and requiring readmission for management. 41,54,55
SECTION 3 : B ACKGROUND-STRATEGIES TO PR EVENT SSI
I. Summary of existing guidelines, recommendations, and requirements
A. CDC and Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines
1.
The most recently published guideline for prevention of SSIs was released in 1999 by Mangram et al. 17 The CDC and HICPAC are currently working on an up-dated version of the guideline with a projected publication date in mid-2014. a. After review of published guidelines, an expert panel identified 3 performance measures for quality improvement related to antimicrobial prophylaxis: 57, 58 i. Delivery of intravenous antimicrobial prophylaxis within 1 hour before incision (2 hours are allowed for the administration of vancomycin and fluoroquinolones).
B. National Institute for Health and Clinical Excellence (NICE)-United Kingdom
ii. Use of an antimicrobial prophylactic agent consistent with published guidelines.
iii. Discontinuation of the prophylactic antimicrobial agent within 24 hours after surgery (dis-continuation within 48
hours is allowable for cardiothoracic procedures in adult patients).
b. The SIP project focused on 7 procedures: abdominal hysterectomy, vaginal hysterectomy, hip arthroplasty, knee arthroplasty, cardiac surgery, vascular surgery, and colorectal surgery.
c. Many hospitals that implemented and improved compliance with SIP performance measures decreased their rates of SSI. 59 D. Surgical Care Improvement Project (SCIP)
1. The SCIP, a multiagency collaboration created in 2003, is an extension of SIP.
2.
In addition to the 3 performance measures of SIP, the SCIP also focuses on 3 additional evidence-supported process measures to prevent SSIs and expanded the types of operations eligible for the performance measures. 58 a. Proper hair removal: no hair removal, although hair removal with clippers or the depilatory method is considered appropriate. Use of razors is considered inappropriate with exception of use on the scrotal area or on the scalp after a traumatic head injury. Because of near-universal compliance with this performance measure, CMS retired the measure in 2012.
b. Controlling blood glucose during the immediate postoperative period for cardiac surgery patients: controlled 6 am blood glucose (200 mg/dL or lower) on postoperative days 1 and 2, with the procedure day being postoperative day 0. In 2014, this measure will be revised to assess glucose control (180 mg/dL or lower) in cardiac surgery pa tients in the time frame of 18-24 hours after anesthesia end time. 60, 61 c. Maintenance of perioperative normothermia in surgical patients who have anesthesia duration of at least 60 minutes.
E. Institute for Healthcare Improvement (IHI)
1. The IHI created a nationwide quality improvement project to improve outcomes in hospitalized patients. 62, 63 2. The IHI recommends the same 6 preventive measures recommended by the SCIP and has included these in the 100,000 and 5 Million Lives Campaigns. 62, 63 F. The Joint Commission National Patient Safety Goals 
2.
Computer-assisted decision support, however, is potentially expensive, can be time-consuming to implement, and in a single study was reported to initially increase the rate of adverse drug reactions. 74 
3.
Institutions must appropriately validate computer-assisted decision support systems after implementation.
D. Utilization of automated data
1.
Install information technology infrastructure to facilitate data transfer, receipt, and organization to aid with tracking of process and outcome measures.
SECTION 4 : RECOMMENDED STRATEGIES FOR SSI PREVENTION
Recommendations are categorized as either (1) basic practices that should be adopted by all acute care hospitals or (2) special approaches that can be considered for use in locations and/or populations within hospitals when HAIs are not controlled by use of basic practices. Basic practices include recommendations where the potential to impact HAI risk clearly outweighs the potential for undesirable effects. Special approaches include recommendations where the intervention is likely to reduce HAI risk but where there is concern about the risks for undesirable outcomes resulting from the intervention, where the quality of evidence is low, or where evidence supports the impact of the intervention in select settings (eg, during outbreaks) or for select patient populations. Hospitals can prioritize their efforts by initially focusing on implementation of the prevention approaches listed as basic practices. If HAI surveillance or other risk assessments suggest that there are ongoing opportunities for improvement, hospitals should then consider adopting some or all of the prevention approaches listed as special approaches. These can be implemented in specific locations or patient populations or can be implemented hospital-wide, depending on outcome data, risk assessment, and/or local requirements. Each infection prevention recommendation is given a quality-of-evidence grade (see Table 1 ).
I. Basic practices for preventing SSI: recommended for all acute care hospitals
1.
Administer antimicrobial prophylaxis according to evidence-based standards and guidelines (quality of evidence: I). 17, 75, 76 a. Begin administration within 1 hour before incision to maximize tissue concentration. 57, 58 Administering agent closer than 1 hour is effective, and some studies show superior efficacy for administration between 0 and 30 minutes prior to incision compared with administration between 30 and 60 minutes. 77, 78 i. Two hours are allowed for the administration of vancomycin and fluoroquinolones.
ii. Many experts believe that antimicrobials should be infused prior to inflation of tourniquets in procedures using "bloodless" techniques, although data are insufficient to support this recommendation. 79, 80 b. Select appropriate agents on the basis of the surgical procedure, the most common pathogens causing SSIs for a specific procedure, and published ii. Vancomycin should be dosed at 15 mg/kg.
iii. Gentamicin should be dosed at 5 mg/kg for adult patients and 2.5 mg/kg for pediatric patients.
(a) For morbidly obese patients receiving gentamicin, the weight used for dose calculation should be the ideal weight plus 40% of the excess weight.
e. Redose prophylactic antimicrobial agents for long procedures and in cases with excessive blood loss during the procedure. 76
i. Prophylactic antimicrobials should be redosed at intervals of 2 half-lives (measured from time the preoperative dose was administered) in cases that exceed this time.
f. Use a combination of parenteral antimicrobial agents and oral antimicrobials to reduce the risk of SSI following colorectal procedures. [84] [85] [86] [87] [88] [89] [90] [91] i. The additional SSI reduction achieved with mechanical bowel preparation has not been studied, but the data supporting use of oral antimicrobials have all been generated in combination with mechanical bowel preparation.
ii. Mechanical bowel preparation without oral antimicrobials does not decrease the risk of SSI. 92 2. Do not remove hair at the operative site unless the presence of hair will interfere with the operation. Do not use razors (quality of evidence: II). 17, 93 a. If hair removal is necessary, remove hair outside the operating room using clippers or a depilatory agent.
3.
Control blood glucose during the immediate postoperative period for cardiac surgery patients 58 (quality of evidence: I) and noncardiac surgery patients [94] [95] [96] [97] [98] (quality of evidence: II).
a. Maintain postoperative blood glucose of 180 mg/dL or lower.
i. iii. Two trials in mixed surgical populations undergoing emergency or elective laparotomy for gastrointestinal, gynecologic, or urologic procedures reported different results. 109, 110 (a) The large multicenter trial that restricted perioperative fluid replacement reported no dif difference. 109 A follow-up study performed in this population noted that patients undergoing cancer surgery who received 80% FiO 2 had higher rates of mortality than patients undergoing cancer surgery who received 30% FiO 2 . 113 (b) The smaller trial without standardized protocols for perioperative normothermia or volume replacement reported an increase in SSIs. 110 In this study, the 80% FiO 2 group had a significantly higher proportion of patients with high body mass index (more than 30), higher blood loss, more crystalloid infused, and longer operations. This group also had 5 patients who remained intubated postoperatively (vs 1 in the 35% group). Postoperative intubation was predictive of SSI.
b.
A meta-analysis of 5 of the above-referenced studies concluded that perioperative supplemental oxygen led to a relative risk (RR) reduction of 25% for SSI. 114 6. Use alcohol-containing preoperative skin preparatory agents if no contraindication exists (quality of evidence: I).
a. Alcohol is highly bactericidal and effective for preoperative skin antisepsis but does not have persistent activity when used alone. Rapid, persistent, and cumulative antisepsis can be achieved by combining alcohol with chlorhexidine gluconate or an iodophor. 115
i. Alcohol is contraindicated for certain procedures, including procedures in which the preparatory agent may pool or not dry (eg, involving hair) due to fire risk. Alcohol may also be contraindicated for procedures involving mucosa, cornea, or ear.
b. The most effective disinfectant to combine with alcohol is unclear.
i. A recent trial of 849 patients undergoing cleancontaminated surgery randomized patients to preoperative skin antisepsis with chlorhexidinealcohol or povidone-iodine. 116 The overall rate of SSI was significantly lower in the chlorhexidinealcohol group than in the povidone-iodine group (9.5% vs 16% [P p . 004]; RR, 0.59 [95% confidence interval (CI), 0.41-0.85]).
ii. In contrast, a single-center study compared povidoneiodine followed by isopropyl alcohol versus chlorhexidine-alcohol versus iodine-alcohol using a sequential implementation design. 117 General surgical patients who received skin antisepsis with iodine-alcohol had the lowest rates of SSI (3.9 per 100 procedures), compared with 6.4 per 100 procedures for patients who received povidone-iodine followed by alcohol and 7.1 per 100 procedures for patients who received chlorhexidine-alcohol.
iii. In the absence of alcohol, chlorhexidine gluconate may have advantages over povidone-iodine, in cluding longer residual activity and activity in the presence of blood or serum. 118, 119 iv. These disinfectants are not interchangeable. Follow the manufacturers' instructions to ensure correct application.
7.
Use impervious plastic wound protectors for gastrointestinal and biliary tract surgery (quality of evidence: I).
a.
A wound protector is a plastic sheath that lines a wound and can facilitate retraction of an incision during surgery without the need for additional mechanical retractors.
b.
A recent meta-analysis of 6 randomized clinical trials in 1,008 patients reported that use of a plastic wound protectors was associated with a 45% decrease in SSIs. 120
i. There was a nonsignificant trend toward greater protective effect using a dual-ring protector compared with a single-ring protector.
8. Use a checklist based on the World Health Organization (WHO) checklist to ensure compliance with best practices to improve surgical patient safety (quality of evidence: I). i. Develop a database for storing, managing, and accessing data collected on SSIs.
ii. Implement a system for collecting data needed to identify SSIs. Data are required from surgical and microbiological databases. Obtain the following data from surgical databases: patient name, medical record number, date, type of procedure, surgeons, anesthesiologists, incision time, wound class, ASA score, closure time, and presence of an SSI. Ideally, these data are supplemented with process data, including prophylactic agent and dose and time(s) of administration of prophylactic agent. For patients diagnosed with an SSI, necessary microbiological data include type of SSI, infecting organism and antimicrobial susceptibilities, and date of infection. More detailed surgical and patient information may be useful for some procedures, including use of general anesthesia, emergency or trauma-related surgery, body mass index, and diagnosis of diabetes.
iii. Prepare periodic SSI reports (time frame will depend on hospital needs and volume of targeted procedures).
iv. Collect denominator data on all patients undergoing targeted procedures in order to calculate SSI rates for each type of procedure. 67
v. Identify trends (eg, in SSI rates and pathogens causing SSIs). i. Procedures that require 90-day surveillance are determined by specific procedure codes.
f. Surveillance should be performed on patients readmitted to the hospital.
i. If an SSI is diagnosed at your institution but the surgical procedure was performed elsewhere, notify the hospital where the original procedure was performed.
g. Develop a system for routine review and interpretation of SSI rates to detect significant increases or outbreaks and to identify areas where additional resources might be needed to improve SSI rates. 125 If increased rates are identified, determine the number of potentially preventable infections that occurred, defined as the number of SSIs that occurred during a procedure in which less than 100% of recommended practices and processes were completed.
10.
Increase the efficiency of surveillance through utilization of automated data (quality of evidence: II).
a. Implement a method to electronically transfer microbiology and operative data, including process measures when available, to IPC personnel to facilitate denominator data acquisition and calculation of SSI rates for various procedures.
b. If information technology and infrastructure resources are available, develop automated methods for detection of SSIs utilizing automated data for readmissions, diagnosis and procedure codes, microbiology results, and antimicrobial dispensing. 35, [126] [127] [128] [129] c. Implementation of automated surveillance may improve the sensitivity of surveillance.
11.
Provide ongoing feedback of SSI rates to surgical and perioperative personnel and leadership (quality of evidence: II).
a. Routinely audit and provide confidential feedback on SSI rates and adherence to process measures to individual surgeons, the surgical division and/or department chiefs, and hospital leadership. 17, 130 i. For each type of procedure performed, provide risk-adjusted rates of SSI.
ii. Anonymously benchmark procedure-specific riskadjusted rates of SSI among peer surgeons. iii. Reduce unnecessary traffic in operating rooms. 135, 136 iv. Appropriate care and maintenance of operating rooms, including appropriate air handling and optimal cleaning and disinfection of equipment and the environment. 17 
Special approaches for preventing SSI
Standard infection control methods of outbreak investigation are recommended for use in locations and/or populations within the hospital with unacceptably high SSI rates despite implementation of the basic SSI prevention strategies listed above.
1.
Screen for S. aureus and decolonize surgical patients with an antistaphylococcal agent in the preoperative setting for high-risk procedures, including some orthopedic and cardiothoracic procedures (quality of evidence: II).
a. Screening for S. aureus refers to the practice of attempting to identify patients colonized with methicillin-susceptible S. aureus (MSSA) and/or MRSA. Decolonization refers to the practice of treating patients with known S. aureus colonization with antimicrobial and/or antiseptic agents to eliminate S. aureus colonization.
i. There is no standardized approach to either screening or decolonizing. Most clinicians attempt to decolonize surgical patients with a combination of chlorhexidine gluconate applied to the skin and nasal mupirocin.
b. A Cochrane review concluded that mupirocin alone may be effective, particularly in certain groups, including orthopedic and cardiothoracic patients. 137 Several nonrandomized trials corroborate this conclusion. [138] [139] [140] c. Clinical practice guidelines from the American Society of Health-System Pharmacists recommend giving mupirocin intranasally to all patients with documented S. aureus colonization for orthopedic procedures, including total joint replacement and hip fracture repair, and cardiac procedures. 76
d. Some trials demonstrate that preoperative screening for S. aureus, coupled with intranasal mupirocin and chlorhexidine bathing is effective in reducing SSI for some patients.
i. For example, a randomized, double-blind, placebocontrolled, multicenter trial that evaluated rapid identification of S. aureus nasal carriers followed by decolonization was associated with a greater than 2-fold reduction in the risk for postoperative infection due to S. aureus and an almost 5-fold reduction in risk for deep incisional SSI due to S. aureus. 141 (a) This study was performed in a setting with high baseline rates of SSI and in the absence of MRSA.
e. In contrast, other trials have failed to demonstrate a benefit.
i. A prospective, interventional cohort study with a crossover design involving 21,000 patients concluded that universal, rapid screening for MRSA at admission coupled with decolonization of carriers did not reduce the rate of SSI due to MRSA. 142
ii. A double-blind randomized controlled trial involving more than 4,000 patients showed that intranasal application of mupirocin, which was not coupled with chlorhexidine bathing, did not significantly reduce the S. aureus SSI rate. 143 (a) In a secondary analysis of these data, the use of intranasal mupirocin was associated with an overall decreased rate of nosocomial S. aureus infections among the S. aureus carriers. b. Determine baseline SSI rates by surgical specialty, procedure, and/or surgeon to better target your evaluation and interventions.
4.
Observe and review operating room personnel and the environment of care in the operating room (quality of evidence: III).
a. Perform direct observation audits of operating room personnel to assess operating room processes and practices to identify infection control lapses, including but not limited to adherence to process measures (antimicrobial prophylaxis choice, timing and duration protocols, hair removal, etc), surgical hand antisepsis, patient skin preparation, operative technique, surgical attire (wearing and/or laundering outside the operating room), and level of operating room traffic. [149] [150] [151] [152] [153] Perform remediation when breaches of standards are identified.
i. Operating room personnel should include surgeons, surgical technologists, anesthesiologists, circulating nurses, residents, medical students, trainees, and device manufacturer representatives. 149
b. Perform direct-observation audits of environmental cleaning practices in the operating room, instrument processing (sterilization), and storage facilities.
i. Review instrument processing and flash sterilization logs.
ii. Review maintenance records for operating room heating, ventilation, and air conditioning system, including results of temperature and relative humidity testing, and test for maintenance of positive air pressure in the operating room(s).
c. Provide feedback and review infection control measures with operating room and environmental personnel.
5.
Observe and review practices in the postanesthesia care unit, surgical intensive care unit, and/or surgical ward (quality of evidence: II). ii. Studies of the efficacy of vancomycin prophylaxis were published prior to the emergence of communityacquired MRSA.
b. Two meta-analyses of studies comparing glycopeptides to blactam antimicrobial prophylaxis concluded that there was no difference in rates of SSI between the 2 antimicrobial prophylaxis regimens. 144, 158 c. A meta-analysis of 6 studies concluded that prophylaxis with a glycopeptide and a second agent was protective against SSI due to gram-positive organisms compared with prophylaxis with a b-lactam alone. 144 Of note, the 2 randomized controlled trials included in the metaanalysis combined a glycopeptide with non-b-lactam antibiotic(s). Thus, no study has prospectively analyzed the effect of providing both glycopeptides and b-lactam antimicrobials for preoperative antimicrobial prophylaxis. As vancomycin does not have activity against gram-negative pathogens and appears to have less activity against MSSA than b-lactam agents, many experts recommend adding vancomycin to standard antimicrobial prophylaxis for the specific clinical circumstances described above. 76,157-159
Do not routinely delay surgery to provide parenteral nutrition (quality of evidence: I).
a. Preoperative administration of total parenteral nutrition has not been shown to reduce the risk of SSI in prospective randomized controlled trials and may increase the risk of SSI. 160, 161 b. Individual trials comparing enteral and parenteral perioperative nutrition and "immunomodulating" diets containing arginine and/or glutamine with "standard" control diets tend to have very small numbers and fail to show significant differences. Two recent meta-analyses, however, demonstrate reduction in postoperative infectious complication in patients receiving enteral diets containing glutamine and/or arginine administered either before or after the surgical procedure. 162 166 In addition, one small study raised concern about higher rates of wound dehiscence while using these sutures. 167 d. The impact of routine use of antiseptic-impregnated sutures on development of resistance to antiseptics is unknown.
4.
Do not routinely use antiseptic drapes as a strategy to prevent SSIs (quality of evidence: I).
a. An incise drape is an adhesive film that covers the surgical incision site to minimize bacterial wound contamination due to endogenous flora. These drapes can be impregnated with antiseptic chemicals, such as iodophors. 168 although this association may have been caused by one specific study. 169 Two trials (abdominal and cardiac surgical patients) compared iodophor-impregnated drapes to no drapes. 170, 171 While wound contamination was decreased in one trial, 170 neither trial demonstrated that iodophorimpregnated drapes decreased the rate of SSI. A nonrandomized retrospective study similarly concluded that impregnated drapes do not prevent SSIs after hernia repair. 172 
Unresolved issues
1.
Preoperative bathing with chlorhexidine-containing products.
a. Preoperative bathing with agents such as chlorhexidine has been shown to reduce bacterial colonization of the skin. 173 Several studies have examined the utility of preoperative showers, but none has definitively proven that they decrease SSI risk. A Cochrane review evaluated the evidence for preoperative bathing or showering with antiseptics for SSI prevention. 174 Six randomized controlled trials evaluating the use of 4% chlorhexidine gluconate were included in the analysis, with no clear evidence of benefit noted. It should be noted that several of these studies had methodological limitations and were conducted several years ago. Thus, the role of preoperative bathing in SSI prevention is still uncertain.
i. To gain the maximum antiseptic effect of chlorhexidine, adequate levels of CHG must be achieved and maintained on the skin. Typically, adequate levels are achieved by allowing CHG to dry completely. New strategies for preoperative bathing with chlorhexidine, such as preimpregnated cloths, have shown promise, 175, 176 but data are currently insufficient to support this approach. b. Gentamicin-collagen sponges are not currently approved by the FDA for use in the United States.
Preoperative intranasal
4.
Use of bundles to ensure compliance with best practices.
a. Bundles have been promoted as methods to improve adherence to best practices.
b.
Although generally favorable, the use of bundles for the prevention of SSI has led to mixed results, depending on which components are included. 59, 187, 188 c. Thus, there is no consensus on the components of an effective bundle to prevent SSIs.
SECTION 5 : PERFORMANCE MEASURES
I. Internal reporting
These performance measures are intended to support internal hospital quality improvement efforts and do not necessarily address external reporting needs. The process and outcome measures suggested here are derived from published guidelines, other relevant literature, and the opinion of the authors. Report process and outcome measures to senior hospital leadership, nursing leadership, and clinicians who care for patients at risk for SSI.
A. Process measures
Compliance with antimicrobial prophylaxis guidelines.
a. Measure the percentage of procedures in which antimicrobial prophylaxis was appropriately provided. Appropriateness includes (1) correct type of agent, (2) start of administration of the agent within 1 hour of incision (2 hours allowed for vancomycin and fluoroquinolones), and (3) discontinuation of the agent within 24 hours after surgery.
i. Numerator: number of patients who appropriately received antimicrobial prophylaxis.
ii. Denominator: total number of selected operations performed.
iii. Multiply by 100 so that the measure is expressed as a percentage.
2.
Compliance with hair removal guidelines.
a. Measure the percentage of procedures for which hair removal is appropriately performed (ie, clipping, use of a depilatory or no hair removal is performed rather than use of razor).
i. Numerator: number of patients with appropriate perioperative hair removal.
3.
Compliance with perioperative glucose control guidelines.
a. Measure the percentage of procedures for which serum glucose is 180 mg/dL or lower within 18-24 hours after anesthesia end time for all cardiac surgery patients. 60,61,100
i. Numerator: number of patients with appropriately maintained serum glucose (180 mg/dL or lower) in the time frame of 18-24 hours after anesthesia end time following cardiac surgery.
ii. Denominator: total number of cardiac procedures performed.
B. Outcome measures
1. SSI rate a. Use NHSN definitions and risk adjustment methods for SSI (available at http://www.cdc.gov/nhsn/acute-care-hospital/ssi/ index.html).
i. Numerator: number of patients with an SSI following selected operations.
iii. Multiply by 100 so that the measure is expressed as the number of SSIs per 100 procedures.
iv. Rates of SSI can be risk adjusted using one of 2 methods: stratification using the NHSN risk index 133 or calculation of the standardized infection ratio (SIR). 189 NHSN now promotes the use of SIR over the NHSN risk index for improved risk adjustment potential, 190 and SIR is preferentially used for the national public reporting outcome measure within NHSN.
(a) The NHSN risk index is an operation and patientspecific prospectively applied risk score that predicts SSIs. 191 This risk index includes 3 predictors of increased risk of SSI: (1) estimators of wound microbial contamination, (2) duration of operation, and (3) markers for host susceptibility. 42 (b) SIR is the ratio of the observed number of SSIs (O) that occurred compared with the expected number for a surgeon performing a specific type of procedure (E; eg, SIR p O/E). 189 The expected number of SSIs can be obtained by multiplying the number of operations done by the surgeon in each procedure risk category by the NHSN rate for the same procedure risk category and dividing by 100. Values that exceed 1.0 indicate that more SSIs occurred than expected. Importantly, SIR can only be calculated if the number of expected HAIs is ≥1. Thus, this approach may be more difficult for small surgical programs or if few procedures are performed for any one procedure type. 192 (c) Risk adjustment using logistic regression and the SIR method generally provides better riskadjustment than the basic risk index. 190, 193 
II. External reporting
There are many challenges in providing useful information to consumers and other stakeholders while preventing unintended adverse consequences of public reporting of HAIs. 194 Recommendations and requirements for public reporting of HAIs have been provided by HICPAC, 195 the Healthcare-Associated Infection Working Group of the Joint Public Policy Committee, 54 the National Quality Forum, 55 and CMS. 196 The following is an example of an external performance measure that is currently required by some healthcare stakeholders and regulators.
A. Process measures
1.
Compliance with CMS antimicrobial prophylaxis guidelines (see the section above on internal reporting in "Section 5: Performance Measures").
a. Measure the percentage of procedures in which antimicrobial prophylaxis was appropriately provided. Appropriateness includes correct type of agent, administration of the agent within 1 hour of incision (2 hours are allowed for vancomycin and fluoroquinolones), and discontinuation of the agent within 24 hours after surgery (48 hours for cardiothoracic procedures). 197 
2.
Compliance with the CMS guideline for control of postoperative blood glucose in cardiac surgery patients. 
SECTION 6 : EXAMPLES OF IMPLEMENTATIONS TRATEGIES
Accountability is an essential principle for preventing HAIs. It provides the necessary translational link between science and implementation. Without clear accountability, scientifically based implementation strategies will be used in an inconsistent and fragmented way, decreasing their effectiveness in preventing HAIs. Accountability begins with the chief executive officer and other senior leaders who provide the imperative for HAI prevention, thereby making HAI prevention an organizational priority. Senior leadership is accountable for providing adequate resources needed for effective implementation of an HAI prevention program. These resources include necessary personnel (clinical and nonclinical), education, and equipment (Table 3 ).
The following information identifies implementation strategies that can be used as part of a program to prevent and reduce the risk for SSI. The implementation strategies are organized under 4 concepts: engage, educate, execute, and evaluate. 199
I. Engage
In the engagement phase, there needs to be clear and effective communication pertaining to the reasons why the SSI implementation strategies are important for patient care. Engagement of senior leadership, physician champions, infection preventionists, and multidisciplinary teams are examples of strategies necessary for initial implementation of a program to reduce SSIs. The following implementation strategies are described in the literature as being essential for the engagement process.
A. Obtaining support for SSI reduction from senior leadership. Senior leadership support is an important factor contributing to SSI rate decreases. Senior leadership is also critical for sustaining improvements over time.
Senior leadership can include but is not limited to the hospital's board, president, chief operating officer, chief medical officer, and chief nursing officer. 148, [200] [201] [202] [203] B. Obtaining highly engaged physicians as champions. Medical and surgical staff engagement is critical for SSI prevention activities and to champion SSI prevention throughout the hospital. Examples include a physician leading an SSI prevention multidisciplinary team and a physician champion who provides education on strategies to reduce SSIs to other physicians and staff. 202, 203 C. Use of multidisciplinary teams. Numerous studies and literature address the effectiveness of multidisciplinary teams to plan, develop, implement, and evaluate efforts to reduce SSIs. The key components of the team include preoperative, intraoperative, and postoperative management of the patient. Teams should include nursing, pharmacy, and physician champions. 148, 200, [204] [205] [206] [207] D. Adopting evidence-based practices and guidelines. Several studies in the literature focus on the need for hospitals to adopt evidence-based practices and guidelines in an effort to decrease the risk of SSIs. The literature stresses that, although evidence-based interventions can reduce the number of SSIs and improve patient outcomes, implementation of these practices nationally occurs less frequently than is desirable. 10, 148, 203, [208] [209] [210] E. Focus on a culture of safety. The literature supports the need for a culture of safety to successfully implement a program focusing on reducing SSIs. A culture of safety focuses on teamwork, technical processes, and promoting accountability for preventing SSIs throughout the continuum of care. 136, 200, 202 II. Educate Education pertaining to practices to prevent SSIs is essential for senior leadership, physicians, nurses, and patients and families. The following implementation strategies describe the types of education that can impact SSI rates and who should be the focus of educational efforts.
A. Aligned and coordinated SSI education for licensed independent practitioners and staff. Multidisciplinary education for licensed independent practitioners (physicians and midlevel practitioners) and other practitioner staff (registered nurses) must be aligned and coordinated. The content of the education focuses on the continuum of the patient's care and execution of evidence-based practices to prevent SSIs. 202, 203 B. One-to-one education of the surgeon when an SSI issue is identified. Provide one-to-one education when surgeons have elevated SSI rates and/or when appropriate preventive processes are not being adhered to. This education may be conducted by another surgeon, infection preventionist, quality office, or other qualified individuals. The education should be nonconfrontational with an emphasis on understanding variation in practice rather than judgment. If lack of adherence to evidence-based practices is identified, then an action plan must be developed. 203 C. Education for senior leadership that describes the value and benefits of SSI reduction. Provide education to executive leadership regarding the value of reducing SSIs, including patient and fiscal outcomes. 131
D.
Education for the surgical team on safety science. Provide education to licensed independent practitioners and staff involved in the care of surgical patients on the science of safety, including the principles of safe system design. 200 E. Specific SSI education for patients and families. Patient education for reducing SSIs is a major priority for any hospital focused on preventing SSIs. Education strategies such as presurgical classes, television education, and one-to-one education with the patient and family have been used successfully. Educational materials should be provided in multiple languages on the basis of the population served. 131, 202, 203 III. Execute
In the execution phase, the focus is on implementation strategies to reduce barriers and improve adherence with evidence-based practices and reduce the risk of SSIs, including (a) standardization of care processes, (b) creating redundancy or independent checks, and (c) learning from defects when an SSI occurs. As noted above, no consensus exists on the components of an effective bundle to prevent SSIs. Thus, individual hospitals must identify local deficits and create their own bundle.
A. Use a quality improvement methodology. Use of quality improvement methodology for designing and implementing a program leads to reduced rates of SSIs. Quality improvement methodologies include Lean Six Sigma, the Comprehensive Unit-Based Safety Program, and the Plan-Do-Check-Act model. Various performance improvement (PI) tools have been used, including dashboards, scorecards, and histograms, to display data. 149, 200, 203, 207, 211 B. Differentiate between adult and pediatric populations. Pediatric-focused evidence-based practices for reducing SSIs are lacking. Clinical interventions designed for the adult population cannot necessarily be transferred to the pediatric population. Hospital and pediatric surgeons must determine whether adult evidence-based interventions can be safely used with the pediatric population. 203
C. Use of information technologies (IT).
IT innovations can be used to simplify and standardize clinical documentation. IT and the electronic medical record can also be used for electronic surveillance, electronic prompts, automatic stops for prophylactic antibiotic orders, and education. Education can be delivered to patients, families, and healthcare workers through different media, including the Internet and television. 148, 202, 203, 212 D. Participation in a collaborative. Numerous studies have reported that participation in a collaborative can help reduce SSI rates in participating organizations. Collaboratives provide a mechanism for organizations to 1. Utilize valid data, such as with the American College of Surgeons National Surgical Quality Improvement Program; 213 2. Identify increased morbidity and mortality through comparisons to peer hospitals on a national basis; 213 and 3. Learn through the collaboration process. 161, 202, 203, 205, 207, 209, 213, 214 E. Use of preoperative/postoperative order sets. Standardized order sets can be developed on the basis of evidencebased practices. The order sets should be approved by the medical staff and updated when the evidence-based practices change. The development of order sets is a labor-intensive process necessitating skills and expertise of several disciplines, including surgery, anesthesia, nursing, and pharmacy. All relevant disciplines should be educated in the use of the order sets. 148, 202, 203 F. Acting on identified SSI issues. When issues suspected of increasing the risk of SSI are identified, the hospital should take action to resolve the identified issues. Several hospitals conduct root-cause analyses with a multidisciplinary team to identify the cause of the issues and any lack of adherence in the evidence-based practices. 149, [202] [203] [204] G. Establish a protocol for preoperative testing. Establish a protocol for procedure-specific preoperative testing to detect medical conditions that increase the risk of SSI. The protocol should focus on nutritional counseling if indicated, smoking cessation if indicated, preadmission infections, and reconciling medications with adjustments prior to surgery if indicated. 202 If high-risk patients are identified through screening, alerts should be added to electronic medical records to ensure that all members of the perioperative team are aware of the high-risk condition(s).
IV. Evaluate
In the evaluation phase, the focus is on the use of measurement and evaluation tools to determine the effectiveness of implementation strategies in the prevention of SSIs.
A. Use of performance improvement tools.
Various PI tools can be used. PI tools include dashboards, scorecards, or histograms to display data. Additional PI tools can include root-cause analysis and failure modes and effects analysis. 148, 202, 203 B. Direct observation of evidence-based practices. As part of a hospital's SSI improvement activities, trained observers (eg, infection preventionists, educators, nurses, and physicians) should observe surgery to assure that evidence-based practices have been implemented in the operating room. Direct observation can also be conducted for hand hygiene and surgical hand antisepsis technique. This activity is used to educate and reinforce evidencebased practices with the operating room practitioners. 136, 149, 203, 214 C. Longitudinal evaluation of SSI rates and compliance rates. Track the success of the SSI reduction program by evaluating SSI rates over time (ie, before, during, and after the program). If specific practices or processes are identified for improvement, evaluate the compliance with evidence-based practices related to these practices and processes. Feed these data evaluations back to frontline staff. Centers for Disease Control and Prevention's National Healthcare Safety Network classification for surgical site infection (SSI). 215 
TABLE 1
Grading of the Quality of Evidence
Grade Definition
I. High Highly confident that the true effect lies close to that of the estimated size and direction of the effect. Evidence is rated as high quality when there is a wide range of studies with no major limitations, there is little variation between studies, and the summary estimate has a narrow confidence interval.
II. Moderate The true effect is likely to be close to the estimated size and direction of the effect, but there is a possibility that it is substantially different. Evidence is rated as moderate quality when there are only a few studies and some have limitations but not major flaws, there is some variation between studies, or the confidence interval of the summary estimate is wide.
III. Low
The true effect may be substantially different from the estimated size and direction of the effect. Evidence is rated as low quality when supporting studies have major flaws, there is important variation between studies, the confidence interval of the summary estimate is very wide, or there are no rigorous studies, only expert consensus.
NOTE. Based on Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) 234 and the Canadian Task Force on Preventive Health Care. 235
TABLE 3
Fundamental Elements of Accountability for Healthcare-Associated Infection Prevention
Senior management is responsible for ensuring that the healthcare system supports an infection prevention and control (IPC) program that effectively prevents healthcare-associated infections (HAIs) and the transmission of epidemiologically important pathogens Senior management is accountable for ensuring that an adequate number of trained personnel are assigned to the IPC program and adequate staffing of other departments that play a key role in HAI prevention (eg, environmental services)
Senior management is accountable for ensuring that healthcare personnel, including licensed and nonlicensed personnel, are adequately trained and competent to perform their job responsibilities Direct healthcare providers (such as physicians, nurses, aides, and therapists) and ancillary personnel (such as environmental service and equipment processing personnel) are responsible for ensuring that appropriate IPC practices are used at all times (including hand hygiene, standard and isolation precautions, and cleaning and disinfection of equipment and the environment)
Senior and unit leaders are responsible for holding personnel accountable for their actions IPC leadership is responsible for ensuring that an active program to identify HAIs is implemented, that HAI data are analyzed and regularly provided to those who can use the information to improve the quality of care (eg, unit staff, clinicians, and hospital administrators), and that evidence-based practices are incorporated into the program Senior and unit leaders are accountable for ensuring that appropriate training and educational programs to prevent HAIs are developed and provided to personnel, patients, and families
Personnel from the IPC program, the laboratory, and information technology departments are responsible for ensuring that systems are in place to support the surveillance program
